Related references
Note: Only part of the references are listed.Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials
Timothy A. Yap et al.
NATURE MEDICINE (2023)
Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia
Natalia Baran et al.
NATURE COMMUNICATIONS (2022)
Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer
Youli Xia et al.
CLINICAL CANCER RESEARCH (2022)
NDUFS3 knockout cancer cells and molecular docking reveal specificity and mode of action of anti-cancer respiratory complex I inhibitors
Ivana Kurelac et al.
OPEN BIOLOGY (2022)
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib
Zhou Zhu et al.
NPJ PRECISION ONCOLOGY (2022)
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
Sergio E. Baranzini et al.
CELL (2022)
Multi-omic molecular profiling reveals potentially targetable abnormalities shared across multiple histologies of brain metastasis
Kazutaka Fukumura et al.
ACTA NEUROPATHOLOGICA (2021)
Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer
Xuxu Gou et al.
CANCER RESEARCH (2021)
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Argun Akcakanat et al.
CLINICAL CANCER RESEARCH (2021)
Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer
Kurt W. Evans et al.
CANCER RESEARCH (2021)
From OCR and ECAR to energy: Perspectives on the design and interpretation of bioenergetics studies
Cameron A. Schmidt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative
Philippe Aftimos et al.
CANCER DISCOVERY (2021)
RNA Sequence Profiling Reveals Unique Immune and Metabolic Features of Breast Cancer Brain Metastases
Limei Xiao et al.
FRONTIERS IN ONCOLOGY (2021)
Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing
Ryan T. Davis et al.
NATURE CELL BIOLOGY (2020)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Florence Coussy et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martinez-Reyes et al.
NATURE COMMUNICATIONS (2020)
Metabolic reprogramming and cancer progression
Brandon Faubert et al.
SCIENCE (2020)
Glucose Metabolic Reprogramming of ER+ Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib
Nicla Lorito et al.
CELLS (2020)
Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage
Siranush Vardanyan et al.
CANCERS (2020)
OXPHOS-dependent metabolic reprogramming prompts metastatic potential of breast cancer cells under osteogenic differentiation
Yangling Hu et al.
BRITISH JOURNAL OF CANCER (2020)
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance
Elodie Montaudon et al.
NATURE COMMUNICATIONS (2020)
Precision of a Clinical Metabolomics Profiling Platform for Use in the Identification of Inborn Errors of Metabolism
Lisa Ford et al.
JOURNAL OF APPLIED LABORATORY MEDICINE (2020)
Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth
Ekta Agarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer
Marina Bacci et al.
CELL REPORTS (2019)
Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes
Paola Lunetti et al.
FEBS JOURNAL (2019)
Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
Kamal Pandey et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Jennifer R. Molina et al.
NATURE MEDICINE (2018)
The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers
Pedram Razavi et al.
CANCER CELL (2018)
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data
Roelof J. C. Kluin et al.
BMC BIOINFORMATICS (2018)
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer
N. C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Breast cancer biomarkers in clinical testing: analysis of a UK national external quality assessment scheme for immunocytochemistry and in situ hybridisation database containing results from 199 300 patients
Andrew Dodson et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
Nicholas C. Turner et al.
LANCET (2017)
HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy
Karen Krukowski et al.
PAIN (2017)
Combating subclonal evolution of resistant cancer phenotypes
Samuel W. Brady et al.
NATURE COMMUNICATIONS (2017)
Mitochondrial markers predict recurrence, metastasis and tamoxifen-resistance in breast cancer patients: Early detection of treatment failure with companion diagnostics
Federica Sotgia et al.
Oncotarget (2017)
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Marina Bacci et al.
CANCER RESEARCH (2016)
A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds
Alejandra Bruna et al.
CELL (2016)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy
Christos E. Zois et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells
Lucas B. Sullivan et al.
CELL (2015)
PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer
Fanny Dupuy et al.
CELL METABOLISM (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Gain of Glucose-Independent Growth upon Metastasis of Breast Cancer Cells to the Brain
Jinyu Chen et al.
CANCER RESEARCH (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Altered tumor-cell glycosylation promotes metastasis
Irina Hauselmann et al.
FRONTIERS IN ONCOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
mTORC1 Controls Mitochondrial Activity and Biogenesis through 4E-BP-Dependent Translational Regulation
Masahiro Morita et al.
CELL METABOLISM (2013)
Long-chain 3-hydroxy fatty acids accumulating in long-chain 3-hydroxyacyl-CoA dehydrogenase and mitochondrial trifunctional protein deficiencies uncouple oxidative phosphorylation in heart mitochondria
Anelise M. Tonin et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2013)
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
Balaraman Kalyanaraman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Quantification of PKC family genes in sporadic breast cancer by qRT-PCR: Evidence that PKCι/λ overexpression is an independent prognostic factor
Khalid Dafaallah Awadelkarim et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Uncoupling proteins and the control of mitochondrial reactive oxygen species production
Ryan J. Mailloux et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Integrated, Nontargeted Ultrahigh Performance Liquid Chromatography/Electrospray Ionization Tandem Mass Spectrometry Platform for the Identification and Relative Quantification of the Small-Molecule Complement of Biological Systems
Anne M. Evans et al.
ANALYTICAL CHEMISTRY (2009)
MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities
Chi V. Dang et al.
CLINICAL CANCER RESEARCH (2009)
Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance
Timothy R. Koves et al.
CELL METABOLISM (2008)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Quantification of estrogen receptor α and β expression in sporadic breast cancer
I Bièche et al.
ONCOGENE (2001)
Share Paper
